Business Description
Cibus Inc
NAICS : 541714
SIC : 2836
ISIN : US17166A1016
Share Class Description:
CBUS: Ordinary Shares - Class ATotal Employee Number:
118Description
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.94 | |||||
Equity-to-Asset | 0.11 | |||||
Debt-to-Equity | 0.91 | |||||
Debt-to-EBITDA | -0.52 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -4.19 | |||||
Beneish M-Score | -2.19 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -22.4 | |||||
3-Year EBITDA Growth Rate | 50.7 | |||||
3-Year EPS without NRI Growth Rate | 51.3 | |||||
3-Year FCF Growth Rate | 63.3 | |||||
3-Year Book Growth Rate | -62.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 41.34 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 162.06 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 54.35 | |||||
9-Day RSI | 53.45 | |||||
14-Day RSI | 50.26 | |||||
3-1 Month Momentum % | -27.78 | |||||
6-1 Month Momentum % | -17.82 | |||||
12-1 Month Momentum % | 3.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.37 | |||||
Quick Ratio | 2.37 | |||||
Cash Ratio | 2.17 | |||||
Days Sales Outstanding | 80.27 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -281.7 | |||||
Shareholder Yield % | -59.09 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -1375.71 | |||||
Net Margin % | -2366.33 | |||||
EBITDA Margin % | -1453.24 | |||||
FCF Margin % | -1181.8 | |||||
OCF Margin % | -1172.42 | |||||
ROE % | -202.76 | |||||
ROA % | -30.91 | |||||
ROIC % | -19.12 | |||||
3-Year ROIIC % | -16.07 | |||||
ROC (Joel Greenblatt) % | -193.19 | |||||
ROCE % | -21.92 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 17.13 | |||||
PB Ratio | 2.95 | |||||
EV-to-EBIT | -1.57 | |||||
EV-to-Forward-EBIT | -2.82 | |||||
EV-to-EBITDA | -1.71 | |||||
EV-to-Revenue | 24.81 | |||||
EV-to-Forward-Revenue | 14.12 | |||||
EV-to-FCF | -2.1 | |||||
Price-to-GF-Value | 0.67 | |||||
Earnings Yield (Greenblatt) % | -63.69 | |||||
FCF Yield % | -48.44 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CBUS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cibus Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 4.286 | ||
| EPS (TTM) ($) | -1.97 | ||
| Beta | 0.7399 | ||
| 3-Year Sharpe Ratio | -0.17 | ||
| 3-Year Sortino Ratio | -0.25 | ||
| Volatility % | 117.36 | ||
| 14-Day RSI | 50.26 | ||
| 14-Day ATR ($) | 0.118582 | ||
| 20-Day SMA ($) | 1.3185 | ||
| 12-1 Month Momentum % | 3.62 | ||
| 52-Week Range ($) | 1.09 - 4.1907 | ||
| Shares Outstanding (Mil) | 76.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cibus Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cibus Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-13 16:30 | In 136 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 135 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-14 16:30 | In 45 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 44 days | ||
| Sidoti Events Small-Cap Virtual Investor Conference | 2026-06-17 11:30 | 1.31 (+2.34%) | ||
| General meeting for 2026 | 2026-06-02 10:00 | 1.47 (+2.80%) | ||
| First quarter earnings conference call for 2026 | 2026-05-14 16:30 | 1.46 (+1.75%) | ||
| First quarter earnings results for 2026 | 2026-05-14 | 1.46 (+1.75%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-17 16:30 | 3.56 (-6.07%) | ||
| Annual report for 2025 | 2026-03-17 | 3.56 (-6.07%) |
Show
Entries
Cibus Inc Frequently Asked Questions
What is Cibus Inc(CBUS)'s stock price today?
The current price of CBUS is $1.37. The 52 week high of CBUS is $4.19 and 52 week low is $1.09.
When is next earnings date of Cibus Inc(CBUS)?
The next earnings date of Cibus Inc(CBUS) is 2026-08-14 Est..
Does Cibus Inc(CBUS) pay dividends? If so, how much?
Cibus Inc(CBUS) does not pay dividend.
Guru Commentaries on NAS:CBUS
No articles.
Press Release
Articles on Cibus Inc
No articles.
Headlines
See More- 1
Jun 09, 2026
Cibus names board member Craig Wichner as new CEO
Seeking Alpha • 11:32pm
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers